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DNA interstrand crosslinks (ICLs) that are repaired
in non-dividing cells must be recognized indepen-
dently of replication-associated DNA unwinding.
Using cell-free extracts from Xenopus eggs that sup-
port neither replication nor transcription, we estab-
lish that ICLs are recognized and processed by the
mismatch repair (MMR) machinery. We find that
ICL repair requires MutSa (MSH2–MSH6) and the
mismatch recognition FXE motif in MSH6, strongly
suggesting that MutSa functions as an ICL sensor.
MutSa recruits MutLa and EXO1 to ICL lesions,
and the catalytic activity of both these nucleases
is essential for ICL repair. As anticipated for a
DNA unwinding-independent recognition process,
we demonstrate that least distorting ICLs fail to
be recognized and repaired by the MMR ma-
chinery. This establishes that ICL structure is a crit-
ical determinant of repair efficiency outside of DNA
replication.INTRODUCTION
DNA interstrand crosslinks (ICLs) are lesions that covalently link
opposing strands of the double helix. ICLs physically block
cellular processes that require the unwinding of the DNA mole-
cule, such as replication, recombination, and transcription.
ICLs can also interfere with essential protein-DNA binding events
such as transcription factor binding. Chemicals that induce ICLs,
such as nitrogenmustards, platinum drugs, andmitomycin C are
therefore extremely cytotoxic and are routinely used in the clinic
as anti-cancer chemotherapies (Deans and West, 2011). Impor-
tantly, ICLs also arise as a consequence of cellular metabolism,
for instance, through production of reactive aldehydes such as
malondialdehyde, acetaldehyde, and formaldehyde (Duxin andCell Re
This is an open access article under the CC BY-NWalter, 2015) or by chemical rearrangements at abasic DNA
sites (Price et al., 2014).
ICLs vary greatly in structure and the degree to which they
distort DNA. These structural differences can influence the
manner in which cells process the ICLs. Indeed, in yeast, the
repair pathway that responds to crosslinking damage differs
according to the crosslinking drug (Beljanski et al., 2004). In
mammalian cells, the efficiency of ICL unhooking and repair
is greater for a distorting ICL than for a non-distorting ICL
(Hlavin et al., 2010; Smeaton et al., 2008). Furthermore, at least
two replication-coupled ICL repair mechanisms have been
described in Xenopus extracts for which the primary determinant
of repair pathway choice is based on ICL structure (Semlow
et al., 2016).
In proliferating cells, most repair occurs during S-phase, when
ICL sensing is a direct consequence of replication. Active repli-
somes stall at ICLs and trigger a complex reaction that requires
the Fanconi anemia (FA) proteins (Ben-Yehoyada et al., 2009;
Klein Douwel et al., 2014; Knipscheer et al., 2009; Ra¨schle
et al., 2008) or the NEIL3 glycosylase (Semlow et al., 2016).
Non-dividing yeast cells grown to stationary phase (Sarkar
et al., 2006) and G1-arrested mammalian cells (Hlavin et al.,
2010; Muniandy et al., 2009; Shen et al., 2006) harness an alter-
native modality of repair termed replication independent repair
(RIR) (Williams et al., 2012). To date, the molecular components
that contribute to RIR have not been fully defined. A fundamental
question that remains unanswered is how ICLs are recognized
without replisome/ICL clashes. Collision between the transcrip-
tion machinery and ICLs could activate repair. Indeed, ICLs are
more efficiently processed when placed in transcribed regions
(Islas et al., 1991), and repair of ICLs placed in constitutively tran-
scribing plasmids shows dependence for transcription-coupled
and global-genome nucleotide excision repair proteins (Enoiu
et al., 2012). However, RIR is initiated in Xenopus extracts in
the absence of both replication and transcription (Ben-Yehoyada
et al., 2009;Williams et al., 2012), suggesting ICLs can be directly
funneled into a repair pathway by DNA damage sensor proteins.
But no ICL sensor has yet been unambiguously identified, and itports 21, 1375–1385, October 31, 2017 ª 2017 The Authors. 1375
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
is not clear how structurally distinct ICL lesions are recognized
and/or subsequently repaired during RIR.
The mismatch repair (MMR) pathway is a highly conserved
DNA repair mechanism that primarily functions to correct repli-
cation errors that escape proofreading. MMR is initiated by the
MutSa complex (MSH2–MSH6 heterodimer), which recognizes
and binds single base mismatches and 1–2 base insertion-dele-
tion loops (IDLs). Binding of MutSa to mispaired bases leads to
the recruitment of downstream DNA repair proteins including
the MutLa endonuclease (MLH1-PMS2 heterodimer), replication
protein A (RPA), EXO1, and proliferating cell nuclear antigen
(PCNA). Together, these proteins catalyze an excision-repair re-
action to restore proper Watson-Crick base-pairing and can
effectively increase the fidelity of replication by up to three orders
of magnitude. In humans, mutations in either subunit of MutSa
(MSH2 and MSH6) account for 50%–60% of germline muta-
tion-based (Lynch syndrome) and 15%–20% of sporadic colo-
rectal cancers (Reyes et al., 2015).
Importantly, MutSa has multiple roles outside of replication.
MutSa is active in quiescent (post-mitotic) mammalian cells,
such as terminally differentiated neurons, where the complex
participates in genome maintenance mechanisms by recog-
nizing not only canonical DNA mismatches, but also responding
to chemically modified DNA bases (Iyama and Wilson, 2013;
Schroering et al., 2007). For example, plasmids containing single
O6-methyl-guanine adducts (O6meG) are processed in a
MutSa-dependent fashion in non-replicating mammalian (York
and Modrich, 2006) and Xenopus extracts (Olivera Harris et al.,
2015), although leading sometimes to futile repair cycles (Fu
et al., 2012). In addition to O6meG, MutSa specifically recog-
nizes bulky lesions such as O4-methylthymine adducts and
cisplatin intrastrand crosslinks in vitro. Crystal structures of hu-
man MutSa bound to these DNA substrates reveal a common
mechanism of damage recognition that requires an N-terminal
FXE motif found in the MSH6 subunit (Warren et al., 2007). Bind-
ing of MutSa to DNA lesions leads to a variety of cellular out-
comes including repair, checkpoint activation, and apoptosis,
underscoring the versatile and critical role that MutSa plays in
genome maintenance.
In this study, we demonstrate a role for the MMRmachinery in
ICL repair. Using non-replicating and transcriptionally silent
Xenopus extracts, we show that MutSa binds to plasmids
bearing a single site-specific ICL and harnesses the entire
MMR machinery, including the MutLa and EXO1 nucleases, to
perform ICL repair. We also compare the repair of structurally
different ICLs, including two analogs of the malondialdehyde
ICL and a nitrogen mustard-like ICL (Guainazzi et al., 2010).
We conclude that ICL structure influences lesion recognition
and repair efficiency during RIR.
RESULTS
MutSa (MSH2–MSH6) Senses DNA ICLs
The MutSa complex recognizes a diverse array of aberrant DNA
structures including base-base mispairs and chemically modi-
fied DNA adducts. We hypothesized that the ability of MutSa
to recognize distortions within DNA might also extend to ICLs,
and that sensing of ICLs by MutSa could initiate ICL repair by1376 Cell Reports 21, 1375–1385, October 31, 2017a set of reactions analogous to MMR. To test this hypothesis,
we first asked whether MutSa binds preferentially to ICLs in
non-replicating Xenopus extracts (high-speed supernatant
[HSS]) using a plasmid pull-down assay. Notably, these cell-
free extracts support ICL repair and restore the integrity of
both DNA strands (Williams et al., 2012).
We used SJG-136, a rationally designed crosslinking drug, to
generate plasmidswith a single site-specific ICL lesion. SJG-136
preferentially forms ICLs between guanine residues at 50-purine-
GATC-pyrimidine-30 sequences (Figure S1A) (Gregson et al.,
2001). We treated oligonucleotide duplexes containing a single
SJG-136 reaction site (Figure S1B) and purified crosslinked du-
plexes by denaturing PAGE. These oligos were ligated into a
small plasmid (pBS: pBlueScript) and further purified by cesium
chloride density ultracentrifugation.
Following incubation in HSS, we isolated plasmid and
plasmid-bound proteins from the extract using biotinylated
lac repressor protein and streptavidin beads, as previously
described (Williams et al., 2012). Western blot analysis revealed
that the crosslinked plasmid was enriched in bound MSH2 and
MSH6when compared to identical undamaged control plasmids
(Figure 1A).
In order to study the dose-dependent response of MutSa to
crosslinks, we conducted a similar experiment with plasmids
containing multiple ICLs by treating double-stranded pBS
plasmids in vitro with increasing doses of SJG-136 (Figures
S1C–S1E). We observed dose-dependent increase of MSH2
and MSH6 binding to damaged plasmids (Figure 1B), after
normalizing for plasmid recovery using qPCR (Figure S1F).
We also observe the recruitment of PCNA and RPA to these
plasmids in a dose-dependent manner, suggesting that the
crosslinked plasmids were undergoing processing and repair.
Consistent with the accumulation of RPA and with our previ-
ous studies (Ben-Yehoyada et al., 2009; Williams et al.,
2012), incubation of the SJG-136-treated plasmids in HSS
triggered phosphorylation of cytosolic Chk1 (Figure S1G), a
marker for ataxia telangiectasia and Rad3-related kinase
(ATR) checkpoint activation.
Next, we asked whether MutSa is required for ICL repair. ICL
plasmids harboring a single, site-specific trimethylene ICL lesion
(50GpC-ICL), for which a nuclear magnetic resonance (NMR)
structure has been described were used as substrates (Protein
Data Bank [PDB]: 2KNL) (Dooley et al., 2003). In contrast to the
temperature-sensitive ICLs generated by SJG-136, the trimethy-
lene crosslink is extremely stable at high temperature. We can
therefore monitor ICL repair by quantitative PCR by comparing
the increase in amplification of the damaged ‘‘X’’ region to that
of an undamaged ‘‘C’’ region on the plasmid backbone over
time (Ben-Yehoyada et al., 2009; Williams et al., 2012) (Fig-
ure S1B, right).
Incubation of cytosol with MSH2 antibodies raised against
Xenopus MSH2 protein depleted both MSH2 and MSH6 sub-
units of MutSa (Figure 1C, left) but did not reduce the cytosolic
levels of other MMR proteins including MLH1 and EXO1 (Fig-
ure 1C, right). Compared to mock-depleted extracts, depletion
of MutSa significantly decreased ICL repair (Figure 1D). Impor-
tantly, addition of recombinant MutSaWT to MSH2-depleted ex-
tracts restored ICL repair to the level of mock-depleted extracts.
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Figure 1. ICL Sensing by MutSa (MSH2–MSH6)
(A) Plasmid pull-down assay of control plasmids or plasmids containing a single site-specific SJG-136 ICL lesion. Plasmids were incubated for 40min in HSS and
then purified from extracts using recombinant Bio-LacRprotein coupled to streptavidin beads. Plasmid-bound proteins were analyzed bywestern blot (WB) using
the indicated antibodies.
(B) Plasmid pull-down assay andWB of SJG-136-treated plasmids. In the last lane, labeled (1032), twice the amount of 10 mM-treated plasmids was incubated in
HSS. Input was plasmid DNA run on an agarose gel.
(C) MSH2–MSH6 immunodepletion. Mock- and MSH2-depleted HSS was analyzed by WB.
(D) Quantification of ICL repair in mock- and MSH2-depleted HSS at 3 hr. Results represent mean ± SEM from n = 7 independent experiments.
(E) Quantification of ICL repair in HSS and HSS supplemented with MutSaWT at 3 hr. Results represent mean ± SEM from n = 11 independent experiments.
See also Figure S1.Moreover, overexpression of MutSaWT in undepleted HSS
increased the ICL repair efficiency (Figure 1E), suggesting that
lesion recognition by MutSa is a rate-limiting step during RIR.
These data establish that MutSa is required for ICL repair in
the absence of DNA replication and transcription.
Mechanism of ICL Recognition by MutSa
MutSa discriminates aberrant DNA substrates amid a vast
excess of normal DNA bases. The MSH6 subunit contributes
critically to this process in at least two ways. First, the MSH6
subunit contains a highly conserved FXE motif (Figures S2A
and S2B) that functions during damage recognition (Lamers
et al., 2000; Malkov et al., 1997): the aromatic ring of the phenyl-
alanine residue stacks with the mispaired base, whereas the
carboxyl group of the glutamic acid residue hydrogen bonds
with the mispaired base (Warren et al., 2007). A single amino
acid substitution of this phenylalanine residue prevents efficient
recognition of mispaired bases in yeast (Bowers et al., 1999) and
results in defective repair in human cell extracts (Dufner et al.,
2000).
To test the possible role of the FXE motif in MutSa-dependent
repair of ICL in Xenopus extracts, we cloned and purified Xeno-pus mismatch binding-deficient MutSaFXE complex (Figures
S2A, S2B, and S2D). First, we asked whether the F411A substi-
tution affected MMR using a plasmid-based MMR assay in HSS
extracts. We used plasmids containing a single A:C mismatch
and a 15-nt gap on the 30 side of the A-strand (pMM1AC) to trigger
gap-directed strand-specific MMR (Figure 2A), as previously
described (Kawasoe et al., 2016). Repair of this plasmid occurs
preferentially on the A-strand, and the correction of the A:C
site to a G:C pair generates a BamHI restriction site (Figure 2A,
top). Background levels of repair on the C-strand are monitored
by digestion with XhoI (Figure 2A, bottom). 60 min after incuba-
tion in mock-depleted extracts, 37% of the A:C mismatches
were repaired to G:C. As anticipated, MMR was abolished in
MSH2-depleted extracts. Addition of recombinant MutSaWT
but not MutSaFXE restored repair (Figure 2A, top). The require-
ment for the FXE motif for MMR is therefore conserved in
Xenopus.
Next, we determined whether the F411A substitution ablated
ICL repair. As shown in Figure 2B, recombinant MutSaFXE
was unable to support repair of ICLs in MSH2-depleted ex-
tracts. The FXE domain is, therefore, critical for ICL damage
recognition.Cell Reports 21, 1375–1385, October 31, 2017 1377
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Figure 2. Mechanism of ICL Recognition by MutSa (MSH2–MSH6)
(A) Plasmids containing a single site-specific A:C mismatch were incubated in mock-depleted, MSH2-depleted, or MSH2-depleted HSS supplemented with
recombinant MutSaWT or MutSaFXE for the indicated amount of time. Mismatch repair efficiency was measured by digestion with XmnI with BamHI or XhoI
restriction enzymes, for A/G repair (top) and C/T repair (bottom), respectively. Data are representative of three independent experiments.
(B) Quantification of ICL repair in mock-depleted, MSH2-depleted, or MSH2-depleted HSS supplemented with recombinant MutSaWT (n = 7), MutSaFXE (n = 6), or
MutSaPIP (n = 4) at 3 hr. Results represent mean ± SEM of independent experiments.
(C) Plasmid pull-down assay and WB of SJG-136-treated plasmids in mock- or PCNA-depleted extract.
See also Figure S2.In addition to recognizing a mismatched base, MSH6 also
interacts with proliferating cell nuclear antigen (PCNA). Studies
using fluorescently tagged proteins show that the interaction
between MSH6 and PCNA is important for the colocalization
of the MutSa complex to replication factories in S. cerevisiae
(Hombauer et al., 2011) and in human cells undergoing MMR
(Kleczkowska et al., 2001). Yet, disruption of the PCNA-MSH6
interface results in a modest MMR phenotype (Shell et al.,
2007), and other PCNA-independent recruitment of MutSa to
mismatches via histone methylation has also been described
(Li et al., 2013).
We used plasmid pull-down assays to ask whetherMutSawas
recruited to ICLs in a PCNA-independent manner. As shown in
Figure 1B, the MutSa complex and PCNA were recruited to
SJG-treated plasmids in HSS extracts. MutSa recruitment was
not dependent on PCNA; MSH2 and MSH6 were efficiently re-
cruited to crosslinked plasmids in PCNA-depleted extracts.
Furthermore, the extent of MutSa recruitment was unaffected
by supplementation of extracts with recombinant PCNA protein1378 Cell Reports 21, 1375–1385, October 31, 2017(Figure 2C). This experiment strongly suggests that MutSa can
be recruited to ICLs independently of PCNA.
The interaction between MSH6 and PCNA is mediated by a
PCNA interaction motif (PIP box) in MSH6 (Clark et al., 2000;
Flores-Rozas et al., 2000). We constructed recombinant MutSa
complex with a triple amino acid substitution in its conserved
PIP box motif: Q(X)2LI(X)2FF (Figures S2A, S2C, and S2D) that
disrupts PCNA interaction with MutSa in vitro (Figure S2G). We
tested the ability of this MutSaPIP to support ICL repair in
MutSa-depleted extracts. We find that MutSaPIP is unable to
support ICL repair (Figure 2B). This indicates that, whereas
MSH6-PCNA interaction is not required for MutSa recruitment
to ICLs, and presumably for ICL sensing, the interaction between
the two is essential for coordinating downstream repair events.
ICLs Are Processed by MutLa and EXO1 Nucleases
The earliest catalytic events during ICL repair are thought to be
dual endonucleolytic incisions flanking the ICL lesion in a pro-
cess referred to as ‘‘unhooking.’’ However, neither the exact
A B C
D E F
Figure 3. Nucleolytic Incision of ICL Lesions by MutLa (MLH1-PMS2)
(A) Schematic of nicking sites engineered into ICL pBS plasmids (see also Figure S3A).
(B) Quantification of ICL repair in HSS of unnicked, 50 or 30 nicked plasmids at 90 min. Results represent mean ± SEM from n = 6 independent experiments.
(C) Plasmid pull-down assay and WB of SJG-136-treated plasmids in mock- or MSH2-depleted extract.
(D) MLH1-PMS2 immunodepletion. Mock- and MLH1-depleted HSS was analyzed by WB.
(E) Quantification of ICL repair inmock-depleted, MLH1-depleted, orMLH1-depletedHSS supplementedwith recombinantMutLaWT (n = 12) orMutLan.d (n = 7) at
90 min. Results represent mean ± SEM independent experiments.
(F) Quantification of ICL repair in HSS with overexpression of buffer, MutLaWT, or MutLan.d. at 90 min. Results represent mean ± SEM from n = 5 independent
experiments.
See also Figure S3.mechanism nor the nuclease(s) involved in the process are
known for RIR.
We engineered the ICL-containing plasmids with 4 unique
nicking sites flanking the ICL (Figures 3A and S3A). We hypoth-
esized that presenting the extract with a pre-nicked plasmid
might stimulate ICL repair if the substrate resembled a physio-
logically relevant ICL repair intermediate. Indeed, introduction
of a single nick 19 bp 50 to the ICL lesion stimulated repair by
4-fold. In contrast, nicks 15 or 30 bp 30 to the ICL or 34 bp 50
to the ICL failed to stimulate repair (Figure 3B). We conclude
that incision 50 to the ICL is a rate-limiting step during the repair
process. It further suggests that a 50 incision close to the ICL (19
versus 34 bp) is optimal for repair and could reflect the physio-
logical site of incision. Finally, the asymmetry between 30 and
50 incisions could reflect the action of 2 distinct nucleases.
Our evidence that MutSa is recruited to ICLs and is required
for their repair prompted us to investigate the possible role of
the mismatch-associated MutLa (MLH1-PMS2 heterodimer)
endonuclease in ICL repair. Recruitment of MutLa to SJG-
136-treated plasmids was observed following incubation of
SJG-136-treated plasmid in extracts (Figure 3C). Notably,
MLH1 recruitment was critically dependent upon MutSa, since
MLH1 binding to the ICL-containing plasmid was abrogated in
MSH2-depleted extracts (Figure 3C).
Specific antibodies against Xenopus MLH1 quantitatively
depleted both MLH1 and PMS2 from extracts (Figure 3D, left).
Importantly, MLH1 depletion did not affect the levels of MSH2and MSH6 in the cytosol (Figure 3D, right), and MSH2 and
MSH6 were still enriched on SJG-136-treated plasmids in
MLH1-depleted extracts (Figure S3E, left). Removal of MLH1/
PMS2 reduced ICL repair by 50%, and addition of recombinant
MutLaWT to MLH1-depleted extract restored repair (Figure 3E).
Therefore, MutLa is not only recruited byMutSa to ICL plasmids,
it is also necessary for efficient ICL repair.
The PMS2 subunit of MutLa complex contains a conserved
endonuclease motif DQHA(X)2E(X)4E. Substitution of E707 to K
abolishes the endonucleolytic activity associated with PMS2
and yields a strong mutator phenotype in S. cerevisiae (Smith
et al., 2013). Mutation of the corresponding residue (PMS2-
E702K) in mice increases genomic mutation rates and cancer
predisposition (van Oers et al., 2010). We generated the equiva-
lent mutation in Xenopus MutLa (MLH1-PMS2E674K) (Figures
S3B–S3D). Recombinant MutLa lacking endonuclease activity
did not support ICL repair in MLH1-depleted extract (Figure 3E).
Furthermore, overexpression of nuclease deficient MutLa com-
plex significantly reduced ICL repair, possibly by acting as a
dominant-negative (Figure 3F). Overexpression of recombinant
MutLa complexes did not interfere with MutSa recruitment to
SJG-136-treated plasmids (Figure S3E, right). These results
indicate that PMS2-associated nuclease activity is required for
ICL repair.
The dual incision flanking the ICL lesion during ‘‘unhooking’’
produces an oligonucleotide that remains covalently attached
to DNA by the ICL adduct and is base-paired on each side ofCell Reports 21, 1375–1385, October 31, 2017 1379
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Figure 4. Nucleolytic Processing of ICL Lesions by EXO1
(A) Plasmid pull-down assay and WB of SJG-136-treated plasmids in mock- or MSH2-depleted extract.
(B) EXO1 immunodepletion. Mock- and EXO1-depleted HSS was analyzed by WB.
(C) Quantification of ICL repair in mock-depleted, EXO1-depleted, or EXO1-depleted HSS supplemented with recombinant EXO1WT or EXO1D173A at 3 hr. Results
represent mean ± SEM from n = 7 independent experiments.
(D) Exo1352 nuclease assay with control or SJG-treated oligonucleotides. Reaction products were run on a denaturing polyacrylamide gel and stained with SYBR
Gold.
See also Figure S4.the ICL. During replication-coupled ICL repair, this DNA frag-
ment is degraded with 50/ 30 polarity by the SNM1A exonu-
clease, presumably allowing DNA polymerases to be loaded
(Wang et al., 2011), and for other downstream repair reactions
to take place.
We speculated that the 50/ 30 EXO1 exonuclease could fulfill
a similar function in RIR. In an in vitro reconstituted vertebrate
MMR system, EXO1 degrades the single-strand oligonucleotide
harboring the mismatch (Genschel et al., 2002). We found that
EXO1 was recruited to SJG-136-treated plasmids. As is the
case for MutLa, EXO1 recruitment was dependent on MutSa:
EXO1 binding to the ICL-containing plasmid was reduced in
MSH2-depleted extracts (Figure 4A). A specific antibody gener-
ated against Xenopus EXO1 quantitatively depleted EXO1 from
extracts (Figure 4B). ICL repair was significantly reduced in
EXO1-depleted HSS. This defect could be rescued by addition
of EXO1WT, but not catalytically inactive EXO1D173A (Figure 4C)
(Liao et al., 2011). This demonstrates that EXO1 and its nuclease
activity are required for ICL repair in the absence of DNA replica-
tion and transcription.
To evaluate the specific contribution of EXO1 during ICL
repair, we conducted in vitro nuclease assays (Wang et al.,
2011). First, we purified the catalytic domain of human EXO1
(EXO1352) from E. coli as previously described (Shi et al.,
2017). EXO1352 harbors robust nuclease activity in vitro but lacks
its C-terminal region (Figure S4A), important for making connec-
tions with various protein binding partners including MSH2,
MLH1, PCNA, and RPA (Shi et al., 2017).1380 Cell Reports 21, 1375–1385, October 31, 2017Duplex oligonucleotides containing a single SJG-136 ICL
lesion are easily distinguished by size from uncrosslinked duplex
on a denaturing polyacrylamide gel (Figure S4B). Similarly, the
reaction products upon incubation with EXO1352 can be visual-
ized and identified. We generated control duplex DNA with
only one free 50 end available for processing (the 50 end of the
other strand blocked by addition of a biotin moiety). This tem-
plate is efficiently processed by EXO1352 from the biotin-free 5
0
end in the 50 to 30 direction as anticipated (Figure 4D, left). Exo-
nucleolytic processing was abolished when both ends of the
duplex are blocked with biotin, confirming that under these
experimental conditions, only the exonuclease activity contrib-
utes to the processing of the DNA substrates. When EXO1352
was incubated with similar ds-DNA oligonucleotides containing
a single SJG-136 ICL lesion, EXO1352 was able to initiate pro-
cessing of the substrate from an available 50 end. However,
EXO1 processing was blocked by the ICL lesion (Figure 4D,
right). EXO1352 is therefore unable to bypass an ICL under these
conditions.
Incubation of plasmids harboring ICL lesions activates the
RPA-ATR-pChk1 branch of the DNA damage response (Fig-
ure S1G). Next, we assessed the role of RPA in ICL repair.
Trimeric RPA protein complex was depleted using an antibody
generated against RPA1. Depletion of RPA from HSS extracts
completely abolished ICL repair. ICL repair was restored by
addition of recombinant Xenopus trimeric RPA complex (Figures
S4C–S4E). This is consistent with our previous studies in which
we reported a requirement for RPA in ICL repair in LSS extracts
A B
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Figure 5. ICL Structure and Repair Efficiency
(A) Structures of normal B-form DNA (PDB: 1BNA) and DNA duplexes containing trimethylene 50 GpC-ICL (PDB: 1LUH) and 50 CpG-ICL (PDB: 2KNK) lesions.
(B) Plasmids containing single trimethylene GpC or CpG-ICL were incubated in HSS, and soluble extracts were analyzed by WB.
(C) Quantification of ICL repair of trimethylene GpC and CpG plasmids at the indicated time points. Results represent mean ± SEM from n = 4 independent
experiments.
(D) Quantification of ICL repair of trimethylene GpC and CpG plasmids in mock- and MSH2-depleted HSS at 3 hr. Results represent mean ± SEM from n = 4
independent experiments.
(E) Quantification of ICL repair of trimethylene GpC and NM-like ICL plasmid using TaqMan qPCR reagent at the indicated time points. Results represent mean ±
SEM from n = 3 independent experiments.
See also Figure S5.(low-speed supernatant) treated with geminin and roscovitine to
inhibit replication (Ben-Yehoyada et al., 2009).
We predicted that RPA binding to crosslinked plasmids during
ICL repair would occur primarily after ICL recognition and initia-
tion of ICL unhooking events. We found that MSH2, MSH6, and
MLH1were loaded to similar levels to SJG-136-treated plasmids
following incubation in mock- and RPA-depleted extracts (Fig-
ure S4F). This result supports amodel in whichMutSa andMutLa
play early roles during ICL repair, preceding nucleolytic events
during the repair.
The Efficiency of RIR Is Influenced by ICL Structure
In replicating extracts, ICLs are sensed by a translocating re-
plisome that stalls at the ICL. In RIR, we suggest ICL sensing
is dependent on distortion of the DNA helix at the lesion. To
test this idea, we compared the kinetics of repair between
chemically related trimethylene ICLs in two distinct structural
conformations: the more distorting 50-GpC-ICL (Dooley et al.,
2003) and the less distorting 50-CpG-ICL (Dooley et al., 2001)
(Figures 5A and S5A). Both ICLs were ligated into a pEGFP
vector backbone (Figure S5B). We found that the more distort-
ing ICL induced a stronger ATR checkpoint activation (Fig-
ure 5B). Furthermore, repair of the more distorting lesion was
40% more efficient than the less distorting lesion (Figure 5C).
We next asked whether repair of these ICLs was dependent
upon MutSa. As shown in Figure 5D, repair of both trimethy-
lene crosslinks displayed a similar requirement for MSH2.
Thus, MutSa is able to recognize structurally distinct ICL
lesions.Finally, we monitored repair of a chemically distinct nitrogen
mustard-like ICL lesion (Figures 5E and S5A). This NM-ICL is
generated within the major groove with minimal distortion of
the DNA helix, allowing the DNA to maintain B-DNA conforma-
tion (Guainazzi et al., 2010; Mukherjee et al., 2014). Interest-
ingly, even after 3 hr of incubation there was no detectable
repair of this NM-ICL (Figure 5E). This supports our notion
that ICL recognition in RIR depends on DNA distortion and is
consistent with a previous report, which indicates that the
repair of NM-ICLs is entirely dependent on replication (Ra¨schle
et al., 2008).
DISCUSSION
MutSa Is a Bona Fide ICL Sensor
The mechanism(s) by which ICLs are sensed and repaired in
non-dividing cells has been difficult to elucidate. In this study,
we used Xenopus HSS extracts, which do not replicate or tran-
scribe, to identify eukaryotic MMR complex, MutSa (MSH2–
MSH6), as a sensor of ICL lesions. Our conclusion is supported
by the following observations. First, MutSawas recruited to plas-
mids containing ICL lesions (Figures 1A and 1B). Second, MutSa
carrying its mismatch binding FXE motif was required for repair
of trimethylene ICLs (Figure 2B). Third, binding of MutSa to ICL
was required for recruitment of downstream repair proteins
including MutLa (Figure 3C) and EXO1 (Figure 4A).
We conclude that binding of MutSa to ICLs precedes nucleo-
lytic processing and thus acts at an early step in ICL repair.
Moreover, overexpression of MutSa in extracts enhanced ICLCell Reports 21, 1375–1385, October 31, 2017 1381
repair efficiency (Figure 1E), further suggesting MutSa senses
ICLs, and that such sensing is a rate-limiting step in repair.
We observe that MutSa-dependent ICL repair has slower ki-
netics than the repair of mismatches in Xenopus extracts (Kawa-
soe et al., 2016; Radman, 2016). We surmise that the complexity
of the ICL lesion, which requires two rounds of repair synthesis
during RIR, could account for this difference.
Importantly, we find that structurally distinct ICLs were re-
paired with varying efficiencies. Trimethylene-ICLs, which signif-
icantly distort DNA, were repaired with robust efficiency, in
contrast to non-distorting NM-like ICLs, which had no detectible
repair (Figures 5C and 5E). This indicates that ICL repair by RIR is
critically dependent on ability of the ICL lesion to be recognized
by DNA damage sensor proteins. Thus, repair of ICLs in G0/G1
utilizes a fundamentally different mechanism than ICL repair dur-
ing S-phase, when lesion sensing occurs by replisomes stalled
at ICLs irrespective of crosslink structure. Moreover, ICL recog-
nition by MutSa during RIR may also be influenced by sequence
context, as has been proposed for MMR (Mazurek et al., 2009).
Of note,MutSa (MSH2–MSH6) is one of twoMMRsensors that
operate during MMR in vertebrates. The other is MutSb (MSH2–
MSH3), which is about 10 times less abundant than MutSa in
mammalian cells and has higher specificity for recognizing larger
IDLs and branched DNA substrates (Genschel et al., 1998).
Depletion of MSH2 from extracts quantitatively depleted MSH6
and MSH3. Our depletion-rescue experiments with recombinant
MutSa, which fully rescues ICL repair, helps assign the speci-
ficity of ICL recognition to MutSa (Figure 1D). In mammalian
cells, MutSb along with the global genome nucleotide excision
repair sensor, XPC (xeroderma pigmentosum complementation
group C) have been linked to psoralen ICL repair (Muniandy
et al., 2009; Thoma et al., 2005; Zhang et al., 2002; Zhao et al.,
2009). However, how these complexes contribute to the repair
of ICLs remains unclear.
Wewere unable to detect direct binding of MutSa to SJG-136-
treated oligonucleotides using electrophoretic mobility shift
assay (EMSA) experiments. This could be due to the design of
the oligo duplex itself, which is restricted in length (20 bases)
to ensure SJG-136 generates a single ICL and to avoid the for-
mation of secondary structures, since the duplexmust be almost
exclusively be composed of A and T nucleotides. While our data
using the mismatch binding deficient (FXE) mutant MutSa (Fig-
ure 2B) strongly suggest that MutSa binding to DNA is critical
for ICL repair, we cannot formally rule out that additional proteins
participate in recruiting MutSa to ICLs.
The Role of PCNA during RIR
Previously, we reported that PCNA is an essential RIR factor. We
showed that PCNA ubiquitinylated at lysine (K164) is required to
recruit Polk to ICL sites for repair synthesis (Williams et al., 2012).
The experiments described here indicate that PCNA is not
essential for MutSa recruitment to ICLs (Figure 2C). However,
we find a requirement for interaction between MutSa and
PCNA for ICL repair (Figure 2B). This suggests that PCNA may
help retain MutSa at damage sites, or perhaps enhanceMutSa’s
damage recognition specificity, as has been suggested during
MMR (Clark et al., 2000; Flores-Rozas et al., 2000; Kleczkowska
et al., 2001). Our data show that PCNA plays an upstream role1382 Cell Reports 21, 1375–1385, October 31, 2017during ICL repair, in addition to supporting Polk recruitment for
repair synthesis.
We also probed the requirement for binding between PCNA
and components of the MMR machinery by generating muta-
tions in the interdomain connector loop (IDCL) of PCNA. Muta-
tions in this region abrogate interactions with MSH6 and PMS2
in vitro, and cause MMR defects in yeast (Lee and Alani, 2006).
We made the equivalent mutations in Xenopus PCNAL126A,I128A
(Figures S2E and S2F). However, we were not able to determine
the contribution of the PCNA:MutSa interface to ICL repair
using the this mutant, since binding between MutSaWT and
PCNAL126A,I128A was enhanced, asmeasured by co-immunopre-
cipitation, compared to binding between MutSaWT and PCNAWT
(Figure S2G). Accordingly, both PCNAWT and PCNAL126A,I128A
were able to rescue ICL repair defects in PCNA-depleted ex-
tracts (Figures S2H and S2I).
Insights into Nucleolytic Processing of ICLs by MutLa
and EXO1
Following sensing, an ICL is thought to be processed in two
consecutive nucleolytic steps. First, dual incisions surrounding
the ICL are made to produce an ‘‘unhooked’’ oligonucleotide,
which is covalently tethered to the DNA by the ICL adduct. The
unhooked lesion is then resected in a ‘‘trimming’’ reaction that
facilitates synthesis past the adduct by translesion synthesis
polymerases by eliminating the need for displacement synthesis
(Roy et al., 2016). In replication-coupled ICL repair the XPF-
ERCC1 endonuclease and SLX4 promote unhooking of ICLs
(Klein Douwel et al., 2014), and the SNM1A exonuclease has
been proposed to process unhooked ICL lesions (Wang et al.,
2011).
We investigated the role of these nucleolytic reactions in RIR.
We used nicked plasmids to identify that a 50 incision 19 base
pairs away from an ICL lesion was able to stimulate repair by
4-fold. This is in contrast to nicks placed 15 or 30 bp 30 to the
ICL or 34 bp 50 to the ICL, all of which failed to stimulate repair
(Figure 3B). This experiment demonstrates a striking mecha-
nistic difference between RIR and MMR. MMR is stimulated
symmetrically by either a 50 or a 30 nick in vitro (Constantin
et al., 2005; Varlet et al., 1996). Our results also suggest that 50
incision is a rate-limiting step during RIR, and that 2 distinct nu-
cleases are required during ICL repair. Depletion-rescue exper-
iments with MutLa strongly suggest that MutLa promotes one or
both of these incisions. However, because it is generally thought
that MutLa requires a pre-existing nick and interaction with
PCNA to stimulate its otherwise latent endonuclease activity, it
is possible that another, as yet unidentified nuclease, is respon-
sible for the initial incision.
Our discovery that MutSa and MutLa participate in ICL repair
highlights the versatile roles DNA repair proteins play in genome
maintenance. This idea is further exemplified by our finding that
EXO1 is required during RIR. EXO1 is a 50/ 30 exonuclease that
is not only involved in MMR, but also plays critical roles in dou-
ble-strand break repair and telomere maintenance (Tran et al.,
2004). In all of these roles, EXO1 catalyzes digestion of DNA by
hydrolyzing phosphodiester bonds between adjoining normal
nucleotides. The requirement for EXO1’s nuclease activity during
ICL repair (Figure 4C) suggests that EXO1 could process
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Figure 6. Model for MMR-Mediated ICL Repair
ICLs can be recognized and repaired in the absence of replication. The MutSa
complex senses and binds ICL lesions and recruits downstream repair pro-
teins including the MutLa endonuclease, PCNA, and EXO1 exonuclease. The
ICL lesion is repaired through a multi-step excision resynthesis reaction. The
latter requires Polk and monoubiquitinated PCNA.complex, chemically modified DNA substrates, including cross-
linked bases. However, our in vitro experiments in which
EXO1352 was unable to bypass an ICL lesion strongly suggests
that EXO1 alone cannot efficiently process ICLs (Figure 4D).
However, it is conceivable that ICL processing by EXO1 requires
association with other proteins through its C terminus.
During replication-coupled ICL repair, SNM1A has been pro-
posed to operate similarly to EXO1 in processing unhooked
ICL lesions (Wang et al., 2011). In addition, there is evidence
that the FAN1 nuclease can digest past ICL-containing oligonu-
cleotides in vitro (Pizzolato et al., 2015; Wang et al., 2014). How-ever, we find that FAN1 depletion in Xenopus HSS extracts has
no effect on ICL repair (unpublished data).
Conclusions
DNA crosslinking agents are among the most widely prescribed
anti-cancer drugs used in the clinic. Yet, acquired resistance re-
mains is a significant limitation of these drugs (Deans and West,
2011). It seems likely that alterations to pathways that contribute
to the repair of ICLs, the principle cytotoxic lesion generated by
these drugs, may underlie acquired resistance. It is therefore
critical to fully understand how cells respond to and repair ICLs.
We provide compelling evidence that the MMR pathway con-
tributes to ICL repair. This is in agreement with a recent study
that used an unbiased proteomic approach to study protein
recruitment to psoralen-ICLs using quantitative mass spectrom-
etry. This study revealed that MSH2, MSH6, PMS2, and EXO1
associate with crosslinked chromatin (Ra¨schle et al., 2015).
Importantly, recruitment of these proteins was resistant to gem-
inin, suggesting that MMR proteins may play a role in ICL repair
both in and beyondG0/G1 phase. Indeed, requirement forMSH2
and EXO1 has been reported in repair of nitrogenmustard ICLs in
S-phase yeast (Barber et al., 2005), and in S-phase mammalian
cells defective in the FA pathway (Huang et al., 2011).
In this study, we provide mechanistic insights into how MMR
proteins cooperate to accomplish ICL repair (Figure 6). We pro-
pose that ICLs that are recognized by MutSa are processed by
MutLa and EXO1 in an incision-excision reaction, followed by
DNA synthesis process that requires PCNA and Polk. Further,
our work stresses the importance of distinguishing between
structurally distinct ICLs, which may be repaired in overlapping
and/or divergent ways. Future experiments should address
whether the sequence context of ICLs influences ICL recognition
and repair.
EXPERIMENTAL PROCEDURES
Xenopus Cell-free Extract and Depletions
Xenopus laevis frogs were handled in accordance with guidelines provided
by the Institutional Animal Care and Use Committee at Columbia University,
protocol AAAK0551. For details regarding the preparation of cell-free extracts
and depleted extracts, see Supplemental Experimental Procedures.
Preparation ICL Plasmids
SJG-136-treated plasmids were prepared by incubating pBS with indicated
concentrations of SJG-136 (NCI/Spriogen LTD) in 50 mM triethanolamine
and 2 mM EDTA, overnight at 37C. Plasmids were ethanol precipitated and
resuspended in water. The quality and quantity of plasmids recovered were
analyzed by agarose gel electrophoresis with ethidium bromide, Nanodrop
measurement, and qPCR. The amount of plasmid used in plasmid pull-down
experiments was normalized accordingly. The preparation of plasmids con-
taining a single SJG-136, trimethylene, or NM-like ICL lesion is described in
detail in Supplemental Experimental Procedures.
ICL Repair and lac Repressor Plasmid Pull-Down Experiments in
Xenopus Extracts
Lac repressor plasmid pull-down assays in undepleted and depleted HSS ex-
tracts were performed as described previously (Williams et al., 2012). ICL
repair assays in HSS were performed essentially as describe previously
(Ben-Yehoyada et al., 2009; Williams et al., 2012). Each of these assays, as
well as the MMR assay of a site-specific A:C mispair is described in detail in
Supplemental Experimental Procedures.Cell Reports 21, 1375–1385, October 31, 2017 1383
Statistical Analysis
All statistical analyseswere performed usingGraphPad Prism 7 software using
paired Student’s t test or ANOVA. Data are annotated as ns = p > 0.05; *p%
0.05; **p% 0.01; ***p% 0.001; ****p% 0.0001.
Protein Expression and Purification
Recombinant MutSa, MutLa, RPA, PCNA, and EXO1 were purified as
described in Supplemental Experimental Procedures.
Reagents
All antibodies and reagents are listed in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2017.10.032.
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